FIRST TRACKS BIOTHERAPEUTICS INC (TRAX) — insider trading
Health Care · NASDAQ
FIRST TRACKS BIOTHERAPEUTICS INC (TRAX) has 147 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 100 (latest 2026-09-15).
Recent Form 4 transactions
Showing the 100 most recent of 147 recorded transactions. See all on SEC EDGAR →
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Orwin John A | Director | Option exercise / conversion (derivative) | 1,300 | — | $0 | Form 4 |
| 2026-09-15 | Orwin John A | Director | Option exercise / conversion | 1,300 | — | $0 | Form 4 |
| 2026-09-02 | Ware J. Anthony | Director | Option exercise / conversion (derivative) | 10,694 | — | $0 | Form 4 |
| 2026-09-02 | Ware J. Anthony | Director | Option exercise / conversion (derivative) | 28,571 | — | $0 | Form 4 |
| 2026-09-02 | Ware J. Anthony | Director | Open-market sale | 39,265 | $44.78 | $1.76M | Form 4 |
| 2026-09-02 | Ware J. Anthony | Director | Option exercise / conversion | 39,265 | $5.74 | $225.4K | Form 4 |
| 2026-08-15 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 193,575 | — | $0 | Form 4 |
| 2026-08-15 | Lizzul Paul F. | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 60,492 | — | $0 | Form 4 |
| 2026-08-15 | STONE BENJAMIN | Officer (Chief Business Officer) | Grant / award / vesting (derivative) | 60,492 | — | $0 | Form 4 |
| 2026-08-02 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 193,576 | — | $0 | Form 4 |
| 2026-08-02 | Lizzul Paul F. | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 60,492 | — | $0 | Form 4 |
| 2026-08-02 | STONE BENJAMIN | Officer (Chief Business Officer) | Grant / award / vesting (derivative) | 60,492 | — | $0 | Form 4 |
| 2026-06-15 | FENTON DENNIS M | Director | Option exercise / conversion (derivative) | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | FENTON DENNIS M | Director | Option exercise / conversion | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Marquet Magda | Director | Option exercise / conversion (derivative) | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Marquet Magda | Director | Option exercise / conversion | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Ware J. Anthony | Director | Option exercise / conversion (derivative) | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Ware J. Anthony | Director | Option exercise / conversion | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Orwin John A | Director | Option exercise / conversion (derivative) | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Orwin John A | Director | Option exercise / conversion | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Schmid John P. | Director | Option exercise / conversion (derivative) | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Schmid John P. | Director | Option exercise / conversion | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Jain Rita | Director | Option exercise / conversion (derivative) | 1,300 | — | $0 | Form 4 |
| 2026-06-15 | Jain Rita | Director | Option exercise / conversion (derivative) | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Jain Rita | Director | Option exercise / conversion | 7,330 | — | $0 | Form 4 |
| 2026-05-12 | Ware J. Anthony | Director | Grant / award / vesting (derivative) | 7,000 | — | $0 | Form 4/A |
| 2026-05-12 | Ware J. Anthony | Director | Grant / award / vesting (derivative) | 2,500 | — | $0 | Form 4/A |
| 2026-05-12 | Schmid John P. | Director | Grant / award / vesting (derivative) | 7,000 | — | $0 | Form 4/A |
| 2026-05-12 | Schmid John P. | Director | Grant / award / vesting (derivative) | 2,500 | — | $0 | Form 4/A |
| 2026-05-12 | Orwin John A | Director | Grant / award / vesting (derivative) | 7,000 | — | $0 | Form 4/A |
| 2026-05-12 | Orwin John A | Director | Grant / award / vesting (derivative) | 2,500 | — | $0 | Form 4/A |
| 2026-05-12 | Marquet Magda | Director | Grant / award / vesting (derivative) | 7,000 | — | $0 | Form 4/A |
| 2026-05-12 | Marquet Magda | Director | Grant / award / vesting (derivative) | 2,500 | — | $0 | Form 4/A |
| 2026-05-12 | Jain Rita | Director | Grant / award / vesting (derivative) | 7,000 | — | $0 | Form 4/A |
| 2026-05-12 | Jain Rita | Director | Grant / award / vesting (derivative) | 2,500 | — | $0 | Form 4/A |
| 2026-05-12 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 7,000 | — | $0 | Form 4/A |
| 2026-05-12 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 2,500 | — | $0 | Form 4/A |
| 2026-05-12 | Lizzul Paul F. | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 72,300 | — | $0 | Form 4 |
| 2026-05-12 | Lizzul Paul F. | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 26,700 | — | $0 | Form 4 |
| 2026-05-12 | Tamboli Ajim | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 13,600 | — | $0 | Form 4 |
| 2026-05-12 | Tamboli Ajim | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 5,000 | — | $0 | Form 4 |
| 2026-05-12 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 271,100 | — | $0 | Form 4 |
| 2026-05-12 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 100,200 | — | $0 | Form 4 |
| 2026-05-12 | STONE BENJAMIN | Officer (Chief Business Officer) | Grant / award / vesting (derivative) | 72,300 | — | $0 | Form 4 |
| 2026-05-12 | STONE BENJAMIN | Officer (Chief Business Officer) | Grant / award / vesting (derivative) | 26,700 | — | $0 | Form 4 |
| 2026-05-12 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 42,000 | — | $0 | Form 4 |
| 2026-05-12 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-05-12 | Orwin John A | Director | Grant / award / vesting (derivative) | 42,000 | — | $0 | Form 4 |
| 2026-05-12 | Orwin John A | Director | Grant / award / vesting (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-05-12 | Jain Rita | Director | Grant / award / vesting (derivative) | 42,000 | — | $0 | Form 4 |
| 2026-05-12 | Jain Rita | Director | Grant / award / vesting (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-05-12 | Schmid John P. | Director | Grant / award / vesting (derivative) | 42,000 | — | $0 | Form 4 |
| 2026-05-12 | Schmid John P. | Director | Grant / award / vesting (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-05-12 | Marquet Magda | Director | Grant / award / vesting (derivative) | 42,000 | — | $0 | Form 4 |
| 2026-05-12 | Marquet Magda | Director | Grant / award / vesting (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-05-12 | Ware J. Anthony | Director | Grant / award / vesting (derivative) | 42,000 | — | $0 | Form 4 |
| 2026-05-12 | Ware J. Anthony | Director | Grant / award / vesting (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-04-23 | Tamboli Ajim | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 41,234 | — | $0 | Form 4 |
| 2026-04-22 | Tamboli Ajim | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 41,233 | — | $0 | Form 4 |
| 2026-04-21 | Tamboli Ajim | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 41,233 | — | $0 | Form 4 |
| 2026-04-21 | Tamboli Ajim | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 45,700 | — | $0 | Form 4 |
| 2026-04-20 | Marquet Magda | Director | Grant / award / vesting (derivative) | 4,000 | — | $0 | Form 4 |
| 2026-04-20 | Marquet Magda | Director | Grant / award / vesting (derivative) | 6,030 | — | $0 | Form 4 |
| 2026-04-20 | Marquet Magda | Director | Grant / award / vesting (derivative) | 5,500 | — | $0 | Form 4 |
| 2026-04-20 | Marquet Magda | Director | Grant / award / vesting (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | Marquet Magda | Director | Grant / award / vesting (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | Marquet Magda | Director | Grant / award / vesting (derivative) | 10,600 | — | $0 | Form 4 |
| 2026-04-20 | Marquet Magda | Director | Grant / award / vesting (derivative) | 9,200 | — | $0 | Form 4 |
| 2026-04-20 | Marquet Magda | Director | Grant / award / vesting (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | Marquet Magda | Director | Grant / award / vesting (derivative) | 784 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 98,600 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 80,512 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 69,355 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 17,850 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 133,400 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 305,500 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 379,620 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 194,900 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 9,200 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 2,321 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | ANAPTYSBIO, INC | 10% owner | Other acquisition or disposition | 100 | — | — | Form 4 |
| 2026-04-20 | Jain Rita | Director | Grant / award / vesting (derivative) | 4,000 | — | $0 | Form 4 |
| 2026-04-20 | Jain Rita | Director | Grant / award / vesting (derivative) | 6,030 | — | $0 | Form 4 |
| 2026-04-20 | Jain Rita | Director | Grant / award / vesting (derivative) | 1,300 | — | $0 | Form 4 |
| 2026-04-20 | Jain Rita | Director | Grant / award / vesting (derivative) | 5,500 | — | $0 | Form 4 |
| 2026-04-20 | Jain Rita | Director | Grant / award / vesting (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | Jain Rita | Director | Grant / award / vesting (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | Jain Rita | Director | Grant / award / vesting (derivative) | 8,015 | — | $0 | Form 4 |
| 2026-04-20 | Jain Rita | Director | Grant / award / vesting (derivative) | 10,600 | — | $0 | Form 4 |
| 2026-04-20 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 4,000 | — | $0 | Form 4 |
| 2026-04-20 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 6,030 | — | $0 | Form 4 |
| 2026-04-20 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 5,500 | — | $0 | Form 4 |
| 2026-04-20 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 10,600 | — | $0 | Form 4 |
| 2026-04-20 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 9,200 | — | $0 | Form 4 |
| 2026-04-20 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | FENTON DENNIS M | Director | Grant / award / vesting (derivative) | 6,000 | — | $0 | Form 4 |
Ask the chat about TRAX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: FIRST TRACKS BIOTHERAPEUTICS INC (TRAX).
Last updated 2026-09-15 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.